224.35 USD
↘ 4.81 (2.10%)AT CLOSE (11:59 AM EDT)
Charles River Laboratories International, Inc.
CRLNYSE • USD
224.34
↘ 0.02 (0.01%)
POST MARKET (AS OF 08:13 PM EDT)
Post Market
AS OF 08:13 PM EDT
224.34
↘ 0.02 (0.01%)
Market: CLOSED
Shares of Charles River Laboratories International, Inc. (CRL) are trading at $224.35. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place CRL at a fair price relative to peers.
Technical & fundamental data as of Jul 17, 2026.
Open?$224.94
High?$228.53
Low?$222.67
Prev. Close?$229.16
Volume?710.2K
Avg. Volume?851.1K
VWAP?$224.97
Rel. Volume?0.83x
Bid / Ask
Bid?$193.00 × 100
Ask?$228.00 × 200
Spread?$35.00
Midpoint?$210.50
Valuation & Ratios
Market Cap?10.8B
Shares Out?48.2M
Float?48.7M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?3.67
EPS?-$3.83
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Employees
19.7K
Market Cap
11.0B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
Listed
2000-06-23
Address
251 BALLARDVALE ST
WILMINGTON, MA 01887
Phone: 781-222-6000
WILMINGTON, MA 01887
Phone: 781-222-6000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?81
Momentum?65
Short Sent.?50
Piotroski F-Score?2/9Weak
Altman Z-Score?3.37Safe
Confidence?62%Moderate
Short InterestElevated
Short % of Float?8.94%Elevated
Short Interest?4.4M
Days to Cover?4.3
Free Float48.7M
Avg Daily Volume1.0M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.36Adequate
Quick Ratio?1.03Adequate
Cash Ratio?0.18Low
Debt/Equity?0.91Moderate
ValuationFAIRLY VALUEDvs 6 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?3.67FAIR▾
Peers86
S&P47
P/S?2.68CHEAP▾
Peers86
S&P55
P/FCF?36.4PRICEY▾
Peers29
S&P20
EV/EBITDA?16.7FAIR▾
Peers86
S&P39
EV/Sales?3.30FAIR▾
Peers86
S&P56
Returns & Efficiency
ROE?-6.3%WEAK▾
Peers14
S&P10
ROA?-2.4%WEAK▾
Peers14
S&P3
Cash Flow & Enterprise
FCF?$296.7M
Enterprise Value?$13.3B
Fundamentals ratios updated end of day